Industry News
Cerylid appoints expat high-flyer to advisory board
Melbourne-based Cerylid Biosciences has appointed another internationally experienced scientist to its advisory board. [ + ]
Eiffel pleased with micronised insulin study
Melbourne-based Eiffel Technologies has announced that a pre-clinical study using micronised insulin demonstrated increased efficacy over native insulin. [ + ]
Research priorities selection committee
An Expert Advisory Committee to advise the Federal Government on the selection of national research priorities has been announced and features people with a wide range of skills and expertise, gathered both in Australia and overseas. The overseas member will be announced soon.
[ + ]Revenues expected, failures weren't, says Amrad boss
Amrad released its end of financial year report on Friday, saying that revenues and expenses were in line with forecasts. [ + ]
Peacock to head Fed research advisory panel
CSIRO Plant Industry chief Dr Jim Peacock has been selected to head the Federal government's advisory panel on national research priorities. [ + ]
Careers in chemistry
A presentation on Careers for Chemists in Biotechnology, scheduled for Monash University next fortnight, has proved popular. [ + ]
New appointments boost BioDiem team
Melbourne drug discovery company BioDiem has appointed two new executives as it gears up for a public listing. [ + ]
Autogen means business with new appointment
Victorian biotech Autogen has appointed a business development director whose role will be to spark new collaborations and capitalise on its IP. [ + ]
Danes, Australians collaborate on 'handmade clones'
Australian and Danish scientists have developed a breakthrough new technique to clone animals they term "handmade cloning." [ + ]
Synchrotron debate heats up
Victorian Treasurer and Innovation Minister John Brumby went on the defensive today after newspapers reported that the Victorian government had approached the Federal government to bail them out of the $57 million hole in the Synchrotron project. [ + ]
Malaria vaccine breakthrough for WEHI
Groundbreaking research on a malaria toxin could lead to the development of an effective vaccine for the deadly disease according to a paper published in the August 15 issue of Nature. [ + ]
Iatia restructures, gears up for sales
Melbourne based company Iatia has announced changes to its management structure to capitalise on the development of new industrial applications for its imaging technology. [ + ]
Fungal threat to eucalypt forests
The eucalypt forests and woodlands are at risk from an exotic disease - a rust fungus capable of attacking a broad range of our unique vegetation.
[ + ]X-ray scientist joins Queensland Institute
Australia's small community of X-ray crystallographers has been strengthened with the arrival of protein crystallography specialist Dr Helen Blanchard at the Centre for Biomolecular Science and Drug Discovery. [ + ]
Papillomavirus vaccine looking positive after Phase I
Promising results have emerged from a two-year Phase I human clinical trial of an Australian-developed therapeutic vaccine targeting cervical cancer. [ + ]
